We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRVL:NASDAQCorVel Corp. Analysis

Data as of 2026-05-26 - not real-time

$62.74

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

CorVel is trading at $62.74, comfortably above its 20‑day SMA of 58.47 and 50‑day SMA of 56.10, indicating short‑term momentum. The 14‑day RSI sits at 63.8, suggesting the stock is approaching overbought territory but still has room for upside. A bullish MACD crossover (MACD line 1.52 above signal 1.05) reinforces the upward bias. Volume is on an increasing trend, supporting the price advance toward the identified resistance of $64.38. However, the 30‑day volatility of nearly 40% and a computed beta of 0.43 signal a price that can swing sharply despite low market‑wide correlation.
Fundamentally, revenue grew 7% to $959 M and EPS rose 17% to $2.14, driven by double‑digit gains in the Network Solutions segment and new payer programs. Operating margins of 15.9% and a ROE of 30.8% reflect strong profitability and capital efficiency. Cash generation remains robust, with operating cash flow of $155 M and free cash flow of $92.9 M, supporting ongoing investments and share repurchases. The balance sheet is conservative, with total debt under $30 M and a debt‑to‑equity of just 7.1. Yet the market values the company at a P/E of 29.3 versus an industry average of 16.8, and the DCF fair value of $36.7 suggests the stock is materially overvalued. The recent earnings release highlighted a 56% jump in quarterly bookings and the rollout of AI‑enabled prepaid solutions, indicating sustainable growth drivers. Given the mix of strong earnings momentum, elevated valuation, and high short‑term price volatility, investors should calibrate exposure accordingly.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and rising volume
  • Price near resistance at $64.38
  • Overvalued relative to DCF and industry P/E

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • 7% revenue growth and 17% EPS increase
  • Strong cash flow generation
  • Continued valuation premium

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • High ROE and low debt profile
  • Secular growth from AI‑enabled prepaid solutions
  • Attractive acquisition potential if price corrects toward DCF

Key Metrics & Analysis

Financial Health

Revenue Growth7.40%
Profit Margin11.51%
P/E Ratio29.3
ROE30.81%
ROA15.05%
Debt/Equity7.13
P/B Ratio8.5
Op. Cash Flow$155.6M
Free Cash Flow$92.9M
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI63.8
Support$55.01
Resistance$64.38
MA 20$58.47
MA 50$56.10
MA 200$67.56
MACDBullish
VolumeIncreasing
Fear & Greed Index91.8

Valuation

Fair Value$36.71
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.43
Volatility39.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.